INTRODUCTION
There is substantial evidence that congenital heart disease (CHD) survivors are at higher risk for developmental delays than the general population. (1) (2) (3) For this reason, neurodevelopment has become one of the most important outcomes being investigated in children with CHD. (1, 2, 4) As many as half of children with CHD present with neurodevelopmental delays characterised by mild impairments across multiple domains, including deficits in gross and fine motor skills, cognition and language, and inattention, impulsivity, impaired executive function and psychosocial problems. (5) (6) (7) (8) For many parents, over time, the neurodevelopmental difficulties faced by their child outweigh the daily burden caused by their heart disease. (9) Developmental delays also have a high cost to society, with costs escalating considerably when the need for developmental intervention is not met and developmental delays are not addressed effectively. (10) The American Heart Association (AHA) published a guideline targeting the evaluation and management of neurodevelopment in the CHD population in 2012, in an attempt to address 
MATERIALS AND METHODS
Information on practitioner characteristics, awareness of the 2012 AHA guideline, and neurodevelopmental evaluation and referral practices were collected using a questionnaire. The questionnaire used in a survey to determine the implementation of the 2012 AHA guideline by cardiac care practitioners in the United States (US), was adapted and expanded. (2, 4) Response options to questions on clinical practice settings were adapted to the South African context. (Table I) .
Most practitioners (n=18; 90%) felt that having neurodevelopmental evaluation and management guidelines for children with CHD was "somewhat" or "very important". Despite this view, the majority (n=16; 80%) were unaware of the 2012 AHA guideline. Awareness was lowest amongst general paediatricians (n=1; 7.1%). The vast majority of practitioners (n=18; 94.7%) did not risk stratify children with CHD in line with the 2012 AHA guideline (Table II) .
Most practitioners (n=15; 75%) routinely performed developmental surveillance. In addition to their own surveillance, several practitioners (n=7; 46.7%) also referred children to an occupational therapist for developmental surveillance. Thirteen practitioners (65%) reported routinely referring children with CHD for developmental screening. Children were referred for screening most often at all care visits (n=15; 75%) and at 6 months of age (n=5; 25%). A single practitioner (5%) used electronic web-based applications for screening (Table II) .
On the identification of developmental difficulties, practitioners most often referred children to allied health services (n=15; 75%) and medical specialists, including paediatric neurologists and neurodevelopmental paediatricians (n=11; 55%), for formal developmental evaluation. Less than a quarter (n=4; 20%) of practitioners referred children to an interdisciplinary clinic for developmental evaluation. Children were usually referred for formal developmental evaluation during infancy (n=14; 70%) and in the pre-school years (n=9; 45%). Referrals were usually based on the practitioner's own concerns about the child's development (n=17; 85%) and/or noted parental concerns (n=16; 80%). Most practitioners (n=15; 75%) referred children diagnosed with a genetic disorder for formal developmental evaluation (n=15; 75%). Only eight practitioners (40%) reported that their referrals for formal developmental evaluation were based on abnormal developmental screening test results (Table III) . Practitioners identified the unavailability of medical specialists including paediatric neurologists and neurodevelopmental paediatricians (n=8; 40%), and the distances families have to travel to access healthcare services (n=8; 40%) as the main barriers to formal developmental evaluation (Table IV) .
When referring children to allied health services, practitioners usually referred children to occupational therapy (n=100%), followed by physiotherapy (n=15; 75%) and then speech therapy (n=14; 70%). Only three practitioners (15%) referred children to a psychologist. Practitioners felt that the unavailability of therapy services (n=15; 75%), the distances families have to travel to access therapy (n=15; 75%) and the time and financial cost to parents in having to take their children to therapy (n=8; 40%), were barriers to accessing intervention therapies (Table IV) .
DISCUSSION
Despite most practitioners indicating that having neurodevelopmental evaluation and management guidelines for children with CHD was important, most (80%) were unaware of the 2012 AHA guideline. Awareness was lowest among the general paediatricians (n=1; 7.1%). A similar lack of awareness of 79% was reported in the US survey. (4) Several factors could explain this lack of awareness. The guideline was published in a cardiovascular journal which may have meant it was less likely to be read by general paediatricians. (4) Paediatric cardiologists and cardiothoracic surgeons are primarily focused on the cardiovascular health of the child with CHD, and may be unaware of or overlook the importance of the child's neurodevelopmental outcome, as a measure of the success of their cardiac interventions. (2, 8, 15) The fact that the guideline is considered "American", despite its universal relevance, may also have deterred South African practitioners from reading it.
Paediatric cardiologists and cardiothoracic surgeons are primarily responsible for the care provided to children with CHD in South Africa. The shortage of paediatric cardiologists in the country makes it highly probable that many children with CHD are cared for by general paediatricians. (16, 17) The poor response from general paediatricians (36.8%) may indicate that they are either not treating children with CHD and/or that they are unaware of the developmental risks faced by these children.
Only three-quarters of practitioners performed routine developmental surveillance at every visit to identify those children at risk for developmental delays. (11) Cardiothoracic surgeons performed no developmental surveillance. This is considered a missed opportunity, as they are ideally situated to identify those children at high risk for developmental delays due to cardiac surgery-related factors such as prolonged cardiopulmonary bypass, (18, 19) the need for cardiopulmonary resuscitation, (20) post-operative seizures, (21) and prolonged postoperative hospital length of stay. (10) Risk-stratification serves to identify those children with CHD considered to be at high risk for developmental delay, and The lack of risk stratification practices in the current study 
CHILDREN WITH CHD

Distance, on average, parents with children with CHD must travel to access intervention therapies and child support services
Less than 50 km 4 (23.5%) 4 (36.4%) 0 0
Greater than 50 km 13 (76.5%) 7 (63.6%) 4 (100%) 2 (100%)
Perceived barriers limiting access of children and their families to intervention therapies *
Availability of therapy services 15 (75%) 11 (78.6%) 4 (100%) 0
Traveling distance to therapy services 15 (75%) 9 (64.3%) 4 (100%) 2 (100%)
Parents feel it is unnecessary, their child is doing well 7 (35%) 6 (42.9%) 1 (25%) 0
Cost of early intervention therapies 5 (25%) 4 (28.6%) 1 (25%) 0
Time required from parents to take children to therapy 8 (40%) 5 (35.7%) 2 (50%) 1 (50%) Time required to adhere to home exercise programmes 8 (40%) 6 (42.9%) 1 (25%) 1 (50%)
Loss of income when taking child therapies 8 (40%) 7 (50%) 1 (25%) 0
Other (siblings at home) 2 (10%) 1 (7.1%) 1 (25%) 0 would mean that a considerable number of children at high risk for developmental delay were not being referred early for formal developmental evaluation. Late referral for formal developmental evaluation would, in turn, also result in the delayed referral to intervention therapies. These findings are consistent with those of the US survey. (4) The 2012 AHA guideline recommends that children with CHD undergo periodic developmental screening with a brief standardised screening tool at 9, 18, 30 and 48 months. (2, 11) Only 65% of practitioners referred children for developmental screening. Screening practices were extremely variable, with referral occurring most often (≤25%) at 6, 12 and 18 months of age. Very few children (≤ 15%) were referred for developmental screening at or after the age of 2 years. These screening practices are likely to result in children with mild developmental delays, behavioural problems and inattention being missed. (1, 10) Contrastingly, many practitioners (n=15; 75%)
reported referring children for developmental screening at every care visit. This screening practice would unnecessarily increase the workload on already over-extended and understaffed healthcare services, and would furthermore limit the number of children who could be accommodated for developmental screening. (17, 22) Referral for developmental screening in the current study was far lower than the 90% of practitioners in the US survey who reported regularly referring children for developmental screening. US practitioners also referred more children aged two years and older for developmental screening. (4) A single practitioner reported using electronic web-based developmental screening applications. Neurodevelopmental experts are of the opinion that it has become imperative to consider the use of innovative technologies to facilitate remote developmental screening and therapy interventions in the CHD population -to counteract the high loss to developmental follow-up. (12, (23) (24) (25) (26) Electronic developmental screening questionnaires could be completed by parents at home and sent on to the practitioner to facilitate remote screening of the child's developmental status. (27) Less than a quarter of practitioners (n=4; 20%) referred at-risk children for formal developmental evaluation, which would include the administration of a comprehensive, standardised developmental test. (2) Children were referred to allied health services (n=15; 75%) and to medical specialists such as a paediatric neurologists or neurodevelopmental paediatricians (n=11; 55%) for formal developmental evaluation. Based on local experience it would be unlikely that a comprehensive, standardised developmental test would be administered at formal developmental evaluations, due to time constraints, a lack of testing expertise and the unavailability of these expensive imported developmental tests. Children were rarely referred for developmental evaluation as scholars or adolescents. This is of concern, as one in three children with CHD have educational concerns, (7, 21) and up to 50% of school-aged children are reported to require intervention therapies and remedial educational services. (6, 7, 28) Around a third of practitioners (n=6) did not refer children for formal developmental evaluation if they were already accessing intervention therapies. The US survey had a similar finding. (4) Intervention therapies are important in effectively addressing developmental delays, but do not replace the need for concurrent formal developmental evaluation. (4) Barriers to formal developmental evaluation are consistent with previous reports, and include a lack of access to the necessary medical specialists, including paediatric neurologists and neurodevelopmental paediatricians (n=8; 40%), and the distance children and their families have to travel to access services (n=8; 40%). (4, 14, 29) Only 20% of practitioners referred children to an interdisciplinary clinic for developmental evaluation, despite an interdisciplinary approach being strongly advocated. (13, 14) The prohibitive infrastructure and human resource costs of establishing dedicated cardiac neurodevelopmental clinics have resulted in the cardiac care community in both the US and Canada recommending that existing, well established interdisciplinary high-risk clinics be used for cardiac neurodevelopmental follow-up. (6, (12) (13) (14) The lack of utilisation of existing high-risk interdisciplinary clinics in the current study is of concern, as this is likely to be the only feasible option for providing cardiac neurodevelopmental follow-up in South Africa.
Children presenting with developmental delays were referred to occupational therapy (100%), physiotherapy (75%) and speech therapy (70%). Children were mostly screened before the age of two years for developmental delays, where motor delays and language deficits are known to be more common. (1) Screening practices would have suggested greater numbers of referrals to physiotherapy and speech therapy to address these developmental delays. It must also be considered that the referral pattern may reflect the therapy services available to children in central South Africa. (30) Children with CHD are at increased risk of behavioural and social difficulties, and are 3 -4 times more likely to present with inattention and hyperactivity than the general population. (2, 7, 19, 21) Only 15% of participants referred children to a psychologist. Reasons for the low number psychologists are a very limited resource in the healthcare sector globally. (31, 32) Perceived barriers to accessing intervention therapies included the distance families had to travel to access therapy, the time required from parents to take their child for therapy, the time required to adhere to the prescribed home exercise programmes, and the loss of income suffered by parents who had to take their children to therapy appointments. Most parents (76.5%) stayed more than 50 kilometres from their closest cardiac centre, where intervention therapies were offered.
The noted barriers are consistent with those in the scant published literature on the feasibility and practicability of providing developmental interventions to children with CHD. (25, 26) 
Limitations
The study findings need to be interpreted in the light of several limitations. Though the survey response rate at 46.7% is higher than the reported average response rate of 33% for online surveys, the sample size was small. (33) Reasons for the nonresponses may have included incorrect email contact addresses, emails being caught up in spam filters, practitioners not considering the survey to be of interest or of relevance to them, and practitioners not having the time to complete the survey due to their already overburdened work schedules. (34, 35) The 
